Stockreport

Why Arcus Biosciences (RCUS) May Be Banking on Partnerships to Accelerate Its Immuno-Oncology Pipeline [Yahoo! Finance]

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF to US$235 million, and announced an expanded collaboration as Taiho Pharmaceutical exercised its option rights for the kidney cancer candidate casdatifan in Asia. This [Read more]